Cargando…
Retraction: Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226906/ https://www.ncbi.nlm.nih.gov/pubmed/35755027 http://dx.doi.org/10.3389/fmed.2022.964099 |
| _version_ | 1784734031131181056 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9226906 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92269062022-06-25 Retraction: Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial Front Med (Lausanne) Medicine Frontiers Media S.A. 2022-06-10 /pmc/articles/PMC9226906/ /pubmed/35755027 http://dx.doi.org/10.3389/fmed.2022.964099 Text en Copyright © 2022 Frontiers Editorial Office. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Medicine Retraction: Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial |
| title | Retraction: Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial |
| title_full | Retraction: Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial |
| title_fullStr | Retraction: Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial |
| title_full_unstemmed | Retraction: Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial |
| title_short | Retraction: Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial |
| title_sort | retraction: proxalutamide reduces the rate of hospitalization for covid-19 male outpatients: a randomized double-blinded placebo-controlled trial |
| topic | Medicine |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226906/ https://www.ncbi.nlm.nih.gov/pubmed/35755027 http://dx.doi.org/10.3389/fmed.2022.964099 |
| work_keys_str_mv | AT retractionproxalutamidereducestherateofhospitalizationforcovid19maleoutpatientsarandomizeddoubleblindedplacebocontrolledtrial |